Literature DB >> 4654860

Pathogenesis of phenylketonuria: inhibition of DOPA and catecholamine synthesis in patients with phenylketonuria.

H C Curtius, K Baerlocher, J A Völlmin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4654860     DOI： 10.1016/0009-8981(72)90406-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  9 in total

1.  Deficits in selective and sustained attention processes in early treated children with phenylketonuria--result of impaired frontal lobe functions?

Authors:  J Weglage; M Pietsch; B Funders; H G Koch; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

2.  Management of the extrapyramidal manifestations of phenylketonuria with L-dopa.

Authors:  M D MacLeod; J F Munro; J G Ledingham; J W Farquhar
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

3.  [Excretion of transamination products in hyperphenylalaninemia (author's transl)].

Authors:  K Olek; P Wardenbach; D Byrd
Journal:  Klin Wochenschr       Date:  1980-02-01

4.  A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.

Authors:  H Blasco; C Veyrat-Durebex; M Bertrand; F Patin; F Labarthe; H Henique; P Emond; C R Andres; C Antar; C Landon; L Nadal-Desbarats; F Maillot
Journal:  JIMD Rep       Date:  2016-06-15

5.  L-dopa in hepatic coma.

Authors:  J E Fischer; F J Funovics; H A Falcao; R I Wesdorp
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

6.  High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Cary O Harding
Journal:  Mol Genet Metab       Date:  2015-11-26       Impact factor: 4.797

Review 7.  A prefrontal dysfunction model of early-treated phenylketonuria.

Authors:  M C Welsh
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

8.  Modulation of cerebral catecholamine concentrations during hyperphenylalaninaemia.

Authors:  C A Brass; O Greengard
Journal:  Biochem J       Date:  1982-12-15       Impact factor: 3.857

9.  Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man.

Authors:  A Niederwieser; H C Curtius; M Wang; D Leupold
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.